Is Dominari Holdings, Inc. overvalued or undervalued?

As of 6 November 2023, the valuation grade for Dominari Holdings, Inc. has moved from does not qualify to risky. The company appears to be overvalued given its financial metrics, particularly with a Price to Book Value of 1.87, an EV to Sales ratio of 2.45, and a troubling ROCE of -169.94%. In comparison to peers, Dominari's EV to EBITDA stands at -1.51, while Frequency Therapeutics, Inc. shows a slightly better EV to EBITDA of -1.0091, indicating that Dominari is lagging behind in operational efficiency.
The stock's current price of 6.33 is significantly below its 52-week high of 13.58, suggesting volatility and potential investor concerns. Although specific return data is not available, the lack of positive performance metrics reinforces the notion that Dominari Holdings is overvalued in the current market context.